Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
NB
NovaBridge Biosciences American Depositary Shares
NBP
Mkt Cap
$147.5M
Volume
341.43K
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
NB
NBP
NB
NovaBridge Biosciences American Depositary Shares
NBP
News
·
NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director
Mkt Cap
$145.7M
Volume
341.43K
Next Earnings
N/A
Chart
Earnings
News
About
Insider
Filings
NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director
NovaBridge Biosciences announced the appointment of Martin Dewhurst, a veteran healthcare executive with over 30 years of experience, to its Board of Directors as an independent director and member of both the Audit and Compensation Committees. Dewhurst brings extensive governance and strategic expertise from his tenure at McKinsey & Company and multiple board positions across biotech, biopharma, and healthcare companies.
GlobeNewswire Inc. · Sep 8, 2026
NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026
NovaBridge Biosciences announced its annual general meeting of shareholders will be held on September 8, 2026, at its Shanghai office. The company, a clinical-stage biopharmaceutical firm, is advancing innovative medicines including givastomig for gastric cancer and VIS-101 for retinal vascular diseases. Shareholders of record as of July 27, 2026, are entitled to attend and vote.
GlobeNewswire Inc. · Jul 24, 2026
NovaBridge to Ring the Nasdaq Opening Bell on Friday, January 2, 2026
NovaBridge Biosciences announced its inclusion in the Nasdaq Biotech Index effective December 19, 2025, and will ring the Nasdaq opening bell on January 2, 2026. The company highlighted this milestone as recognition of its strategic vision and pipeline strength as a global biotechnology platform focused on developing innovative medicines.
GlobeNewswire Inc. · Dec 30, 2025
NovaBridge Announces Presentation of Ragistomig Expanded Phase 1 Data at ESMO-IO
NovaBridge Biosciences and ABL Bio reported positive Phase 1 dosing study results for ragistomig, a 4-1BB X PD-L1 bispecific antibody designed to treat patients resistant to checkpoint inhibitors, with extended dosing interval showing strong anti-tumor efficacy and improved safety profile.
GlobeNewswire Inc. · Dec 4, 2025
NovaBridge’s Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward
NovaBridge's subsidiary Visara appointed Dr. Cadmus C. Rich as Chief Medical Officer and Dr. Carlos Quezada-Ruiz as Scientific Advisory Board Chair to advance VIS-101, a novel bifunctional biologic targeting VEGF-A/ANG2 for treating retinal diseases.
GlobeNewswire Inc. · Nov 21, 2025
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
NB
NBP
NovaBridge Biosciences American Depositary Shares
Buy
Sell
Market
Limit
Soon
NBP
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any NBP yet.
Related Tickers
Earnings